Inventor

SAARMA MART

FI22 patents

⚠️ This page may combine multiple inventors who share the name “SAARMA MART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAARMA MART

SAARMA MART

MANF2 for treatment of Parkinson&#39;s disease

Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators

Receptor for GDNF family ligands

Treatment with a pharmaceutical composition comprising MANF2 necleic acid

Neurotrophic factor MANF and uses thereof

LICENTIA LTD

Neurotrophic factor protein and uses thereof

Assays using glial cell line-derived neurotrophic factor receptors

Compounds related to or derived from GFR α4 and their use

CEPHALON INC

Methods for preventing/treating damage to sensory hair cells and cochlear neurons

Methods for preventing/treating damage to sensory hair cells and cochlear neurons

NEVALAITA LIINA

Splice variants of GDNF and uses thereof

Splice variants of GDNF and uses thereof

NTF THERAPEUTICS INC

Neurturin molecules

Neurturin molecules

(unassigned)

Glial cell line-derived neurotrophic factor regulation of ureteric budding and growth

KEMIRA OY BIOTECH

Transgenic plants displaying multiple virus resistance and a process for their production

HERANTIS PHARMA PLC

Neurotrophic factor MANF and uses thereof

PENN RICHARD

Neurturin molecules

BALTIC TECHNOLOGY DEV LTD

Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease

MYNEUROCURE OY

C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof

LICESTIA LTD

Ret-independent signaling pathway for GDNF

ARUMAEE URMAS

Method of screening cell death modulators

MANF2 for treatment of Parkinson's disease